A Web-Based Dyadic Intervention for Colorectal Cancer
Emory University · with Oncology Nursing Society · NCT05663203
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 56
- US sites recruiting
- 1
- Study start
- May 1, 2023
- Record last updated
- December 19, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include fatigue, depression, sleep disturbance, pain, and cognitive dysfunction. When these co-occurring symptoms are undertreated, they negatively affect functional status, survival rates, and quality of life of patients as well as decrease health outcomes of their family caregiver. A critical need exists to develop an effective and novel intervention that focuses on patients with colorectal cancer receiving chemotherapy and their caregivers. A web-based dyadic intervention holds great promise to reduce psychoneurological symptoms burden and improve quality of life for patients with colorectal cancer receiving chemotherapy and advance intervention development and implementation in cancer supportive care and health equity.
Being studied: Internet-Based Intervention; Interview; Survey Administration; Electronic Health Record Review
Conditions: Colorectal Carcinoma
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
INCLUSION CRITERIA
Patients
- Age >= 18 years
- Diagnosed with colorectal cancer
- Life expectancy > 12 months
- Receiving active chemotherapy
- Self-reported at least two psychoneurological symptoms (based on the symptom measures' cutoff scores)
- Identified primary caregiver (i.e., family members or significant others identified by the patients as their primary source of emotional and physical support)
- Access to the Internet
- Fluent in English
Caregivers
- Age >= 18 years
- Primary caregiver
- Access to the Internet
- Fluent in English
EXCLUSION CRITERIA
Patients
- Karnofsky Performance Scale \< 50
Caregivers
- Have severe diseases (e.g., cancer, heart disease)
Recruiting US locations
Emory University/Winship Cancer Institute
Atlanta, GA 30322
Site contact: Yufen Lin, PhD, RN · 404-712-9823 · yufen.lin@emory.edu
Study contacts (from the official record)
- Yufen Lin, PhD, RN · 404-712-9823 · yufen.lin@emory.edu
- Canhua Xiao, PhD, RN · 404-712-9823 · canhua.xiao@emory.edu
Similar studies in Georgia
All healthy volunteers studies in Georgia →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Influenza Human Challenge Model
Emory University
- Location
- Atlanta, GA + 1 other US site
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A/Texas Flu Challenge
Emory University
- Location
- Atlanta, GA + 1 other US site
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Atlanta, GA + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Decatur, GA + 49 other US sites
- Eligibility basics
- Ages 60+